Literature DB >> 6972989

Adjuvant polyarthritis. V. Induction by N-acetylmuramyl-L-alanyl-D-isoglutamine, the smallest peptide subunit of bacterial peptidoglycan.

Y H Chang, C M Pearson, L Chedid.   

Abstract

N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP), an apparently nonimmunogenic bacterial peptidoglycan-derived small peptide, was found to induce a polyarthritis the rat similar to that induced by Freund's complete adjuvant when injected in the form of an oil emulsion. An oil emulsion of its isomer, N-acetylmuramyl-L-alanyl-L-isoglutamine, which unlike MDP has no immunostimulatory activity, failed to induce the disease.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6972989      PMCID: PMC2186125          DOI: 10.1084/jem.153.4.1021

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  19 in total

1.  PASSIVE TRANSFER OF ADJUVANT ARTHRITIS BY LYMPH NODE OR SPLEEN CELLS.

Authors:  C M PEARSON; F D WOOD
Journal:  J Exp Med       Date:  1964-10-01       Impact factor: 14.307

2.  Development of arthritis, periarthritis and periostitis in rats given adjuvants.

Authors:  C M PEARSON
Journal:  Proc Soc Exp Biol Med       Date:  1956-01

3.  Adjuvant polyarthritis. III. Evidence in support of viral etiology.

Authors:  Y H Chang; W Hoffman
Journal:  Arthritis Rheum       Date:  1977 Nov-Dec

Review 4.  Biological activities of muramyl dipeptide, a synthetic glycopeptide analogous to bacterial immunoregulating agents.

Authors:  L Chedid; F Audibert; A G Johnson
Journal:  Prog Allergy       Date:  1978

5.  Degradation of 14 C-labeled group A streptococci and micrococci in muscular lesions in the mouse.

Authors:  E Adler; H Heller; E Weiner; A Masover; S Friedman; M Lahav; N Ne'eman; I Ginsburg
Journal:  Isr J Med Sci       Date:  1973-04

6.  Adjuvant polyarthritis I: incorporation of quantitative measurements of humoral and cellular immune response.

Authors:  Y H Chang
Journal:  J Pharmacol Exp Ther       Date:  1977-04       Impact factor: 4.030

7.  Structural requirements for arthritogenicity of peptidoglycans from Staphylococcus aureus and Lactobacillus plant arum and analogous synthetic compounds.

Authors:  O Kohashi; C M Pearson; Y Watanabe; S Kotani; T Koga
Journal:  J Immunol       Date:  1976-06       Impact factor: 5.422

8.  Preparation of various fractions from Mycobacterium smegmatis, their arthritogenicity and their preventive effect on adjuvant disease.

Authors:  O Kohashi; C M Pearson; T Shimono; S Kotani
Journal:  Int Arch Allergy Appl Immunol       Date:  1976

9.  Adjuvant polyarthritis. IV. Induction by a synthetic adjuvant: immunologic, histopathologic, and other studies.

Authors:  Y H Chang; C M Pearson; C Abe
Journal:  Arthritis Rheum       Date:  1980-01

10.  Suppression of adjuvant disease in the rat by heterologous antilymphocyte globulin.

Authors:  H L Currey; M Ziff
Journal:  J Exp Med       Date:  1968-01-01       Impact factor: 14.307

View more
  15 in total

1.  Arthritis induced in rats with adjuvant oil is a genetically restricted, alpha beta T-cell dependent autoimmune disease.

Authors:  R Holmdahl; T J Goldschmidt; S Kleinau; C Kvick; R Jonsson
Journal:  Immunology       Date:  1992-06       Impact factor: 7.397

2.  PGLYRP-2 and Nod2 are both required for peptidoglycan-induced arthritis and local inflammation.

Authors:  Sukumar Saha; Jin Qi; Shiyong Wang; Minhui Wang; Xinna Li; Yun-Gi Kim; Gabriel Núñez; Dipika Gupta; Roman Dziarski
Journal:  Cell Host Microbe       Date:  2009-02-19       Impact factor: 21.023

3.  Extraintestinal manifestations of granulomatous enterocolitis induced in rabbits by long-term submucosal administration of muramyl dipeptide emulsified with Freund's incomplete adjuvant.

Authors:  K Kuroe; Y Haga; O Funakoshi; I Mizuki; K Kanazawa; Y Yoshida
Journal:  J Gastroenterol       Date:  1996-04       Impact factor: 7.527

4.  Two adjuvant-active muramyl dipeptide analogs induce differential production of lymphocyte-activating factor and a factor causing distress in guinea pigs.

Authors:  N E Byars
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

5.  Role of peptidoglycan subtypes in the pathogenesis of bacterial cell wall arthritis.

Authors:  E Simelyte; M Rimpiläinen; X Zhang; P Toivanen
Journal:  Ann Rheum Dis       Date:  2003-10       Impact factor: 19.103

6.  Different effect of cyclosporin A on arthritides induced by a muramyl dipeptide analogue or the complete adjuvant in rats.

Authors:  T Sugawara; S Takada; K Furuhama; S Takayama; M Nomura; M Kato
Journal:  Int J Exp Pathol       Date:  1995-06       Impact factor: 1.925

7.  Chronic arthritis induced in rats by cell wall fragments of Eubacterium species from the human intestinal flora.

Authors:  A J Severijnen; R van Kleef; M P Hazenberg; J P van de Merwe
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

8.  Adjuvant polyarthritis. VIII. Differences in immunopathogenesis between type II collagen arthritis and adjuvant arthritis.

Authors:  Y H Chang; Y Iizuka
Journal:  Agents Actions       Date:  1984-12

9.  Development of an experimental animal model for reactive arthritis induced by Yersinia enterocolitica infection.

Authors:  J L Hill; D T Yu
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

Review 10.  Adjuvant polyarthritis in rats: is this a satisfactory model for screening anti-arthritic drugs?

Authors:  K D Rainsford
Journal:  Agents Actions       Date:  1982-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.